SCHEMBL5825872

SCHEMBL5825872

CCCC(CCN1CCN(C)CC1)OC(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 13/20 0.55
KIT P10721 4/20 0.55
KDR P35968 11/20 0.54
MET P08581 3/20 0.51
FLT3 P36888 2/20 0.51
AURKB Q96GD4 2/20 0.51
AXL P30530 4/20 0.51
AURKA O14965 1/20 0.50
RIPK2 O43353 1/20 0.50
ABCB11 O95342 1/20 0.50
ABL1 P00519 1/20 0.50
EGFR P00533 1/20 0.50
ERBB2 P04626 1/20 0.50
NTRK1 P04629 1/20 0.50
LCK P06239 1/20 0.50
PGR P06401 1/20 0.50
LYN P07948 1/20 0.50
RET P07949 1/20 0.50
CHRM2 P08172 1/20 0.50
HCK P08631 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5825841 0.94 PDGFRA (0.59) PDGFRAKITKDRMETFLT3
SCHEMBL5825581 0.92 MET (0.59) PDGFRAKITKDRMETEGFR
SCHEMBL5824540 0.90 PDGFRA (0.66) PDGFRAKITKDRMETFLT3
SCHEMBL5824383 0.88 KDR (0.61) PDGFRAKITKDRMETFLT3
SCHEMBL5825575 0.86 PDGFRA (0.64) PDGFRAKITKDRMETFLT3
SCHEMBL5825509 0.85 MET (0.46) KITKDRMETFLT3AXL
SCHEMBL5824763 0.85 MET (0.47) KITKDRMETFLT3AXL
SCHEMBL5824675 0.85 PDGFRA (0.64) PDGFRAKITKDRMETFLT3
SCHEMBL5824696 0.84 PDGFRA (0.58) PDGFRAKITKDRMETFLT3
SCHEMBL5824830 0.83 PDGFRA (0.66) PDGFRAKITKDRMETFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PDGFRA 1/4885KIT 401/4885KDR 4/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PDGFRA 1/4885KIT 499/4885KDR 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.